Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activities.

Autor: Ruhlmann, Marcus, Sonnenschein, Wilfried, Nagarajah, James, Binse, Ina, Herrmann, Ken, Jentzen, Walter
Zdroj: Nuclear Medicine Communications; May2018, Vol. 39 Issue 5, p457-464, 8p
Databáze: Complementary Index